Supplementary Table S1 from Ablation of p57⁺ Quiescent Cancer Stem Cells Suppresses Recurrence after Chemotherapy of Intestinal Tumors par Takeru Oka (15386810)

Sujets:

Source Data from Ablation of p57⁺ Quiescent Cancer Stem Cells Suppresses Recurrence after Chemotherapy of Intestinal Tumors par Takeru Oka (15386810)

Sujets:

Electrophysiological development and functional plasticity in dissociated human cerebral organoids across multiple cell lines - Raw MEA data (2 of 4) par Adam Pavlinek (20917388)

Sujets: “…human induced pluripotent stem cells…”

Electrophysiological development and functional plasticity in dissociated human cerebral organoids across multiple cell lines - Well average data and metadata (1 of 4) par Adam Pavlinek (20917388)

Sujets: “…human induced pluripotent stem cells…”

Supplementary Table S1 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target par Ana Vujovic (15207479)

Sujets:

Supplementary Table S4 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target par Ana Vujovic (15207479)

Sujets:

Supplementary Table S9 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target par Ana Vujovic (15207479)

Sujets:

Supplementary Table S8 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target par Ana Vujovic (15207479)

Sujets:

Supplementary Table S5 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target par Ana Vujovic (15207479)

Sujets:

Supplementary Table S7 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target par Ana Vujovic (15207479)

Sujets:

Supplementary Table S3 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target par Ana Vujovic (15207479)

Sujets:

Supplementary Table S6 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target par Ana Vujovic (15207479)

Sujets:

Supplementary Table S2 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target par Ana Vujovic (15207479)

Sujets:

Figure 3 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia par Natalia Colomar-Carando (14611340)

Sujets:

Figure 4 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia par Natalia Colomar-Carando (14611340)

Sujets:

Figure 2 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia par Natalia Colomar-Carando (14611340)

Sujets:

Figure 1 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia par Natalia Colomar-Carando (14611340)

Sujets:

Figure 5 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia par Natalia Colomar-Carando (14611340)

Sujets:

Supplementary file 1_Drug combination discovery assisted by AI and untargeted metabolomics: pamiparib and anlotinib synergistic potentiation for ovarian cancer treatment.docx par Dong Wang (73290)

Sujets:

Table 5_Establishment and transcriptomic characterization of canine organoids from multiple tissues.xlsx par Christopher Zdyrski (11516168)

Sujets: